Substituted phenethylamines
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Sepehr Sarshar
Life of this patent
Estimating the term…
Abstract
Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
Claims55
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt or enantiomer thereof.
A pharmaceutical composition comprising one or more pharmaceutically acceptable carriers and a compound selected from the group consisting of:
- or a pharmaceutically acceptable salt or enantiomer thereof.
A method for the treatment, prevention, or amelioration of one or more symptoms of an alpha adrenergic receptor-mediated disorder, in a subject, comprising administering a therapeutically effective amount of a compound selected from the group consisting of:
- or a pharmaceutically acceptable salt or enantiomer thereof.
A pharmaceutical composition comprising one or more pharmaceutically acceptable carriers and a compound having the structural formula:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising one or more pharmaceutically acceptable carriers and a compound having the structural formula:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising one or more pharmaceutically acceptable carriers and a compound having the structural formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.